Novita Pharmaceuticals, Inc. — Form D/A
Novita Pharmaceuticals, Inc. of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2017-04-06. The offering totals $6.5M, of which $6.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-04-06
- Form: D/A
- Accession: 0000897069-17-000216
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.5M
- Amount sold: $6.5M
- Minimum investment: $51K
- Investors: 30
- Date of first sale: 2016-11-04
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-273682
Issuer
- Name: Novita Pharmaceuticals, Inc.
- CIK: 0001509360
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 1161 YORK AVE, APT #8C, NEW YORK, NY, 10065
- Phone: (646) 939-5517
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Chenjian Jullian Li | Director | New York, NY |
| Jue Jullian Zhang | Director | New York, NY |
| David Jullian Moy | Executive Officer | New York, NY |
| Jue Jullian Zhang | Executive Officer | New York, NY |
| Xin-Yun Y Huang | Director | New York, NY |
| Xin-Yun Y Huang | Executive Officer | New York, NY |
| David Jillian Moy | Executive Officer | New York, NY |
| Chenjian Jillian Li | Director | New York, NY |
| Christy Y Shue | Director | New York, NY |
| Christy Y Shue | Executive Officer | New York, NY |
| Jonathan Jia Zhu | Director | BOSTON, MA |
| Jue Jillian Zhang | Director | New York, NY |
| Jue Jillian Zhang | Executive Officer | New York, NY |
Other filings by this issuer (4)
More